drugset / Trial / NCT05915286

Diuretic Use in Hemodialysis Patients With Residual Renal Function

NCT05915286

Phase 4 Terminated 2 enrolled University of Alberta
NaSingle-groupOpen-labelTreatment

Summary

This pilot trial will evaluate the use of diuretic medications (furosemide and chlorthalidone) in participants on dialysis to see if these medications work to preserve existing kidney function, increase urine output, and reduce weight gain between dialysis treatments. Diuretics, which are sometimes called water pills, help the body to get rid of salt (sodium) and water. There are currently no guidelines for the use of diuretic medications in dialysis patients, including the type to use, or how much to use.

Timeline

Start
2023-05-29
Primary completion
2025-02-21
Completion
2025-02-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorthalidone Other / unclassified
Subject Furosemide Other / unclassified